Frontiers in Genetics (Dec 2020)
hMZF-2, the Elusive Transcription Factor
- Alain Chebly,
- Alain Chebly,
- Jean-Marie Peloponese,
- Evelyne Ségal-Bendirdjian,
- Jean-Philippe Merlio,
- Jean-Philippe Merlio,
- Roland Tomb,
- Roland Tomb,
- Edith Chevret
Affiliations
- Alain Chebly
- Bordeaux University, INSERM U1053 Bordeaux Research in Translational Oncology (BaRITOn), Cutaneous Lymphoma Oncogenesis Team, Bordeaux, France
- Alain Chebly
- Medical Genetics Unit (UGM), Faculty of Medicine, Saint Joseph University, Beirut, Lebanon
- Jean-Marie Peloponese
- University of Montpellier, CNRS IRIM-UMR 9004, Research Institute in Infectiology of Montpellier, Montpellier, France
- Evelyne Ségal-Bendirdjian
- Université de Paris, INSERM UMR-S 1124, Team: Cellular Homeostasis, Cancer and Therapies, INSERM US36/CNRS UMS 2009, BioMedTech Facilities, Paris, France
- Jean-Philippe Merlio
- Bordeaux University, INSERM U1053 Bordeaux Research in Translational Oncology (BaRITOn), Cutaneous Lymphoma Oncogenesis Team, Bordeaux, France
- Jean-Philippe Merlio
- Bordeaux University Hospital Center, Tumor Bank and Tumor Biology Laboratory, Pessac, France
- Roland Tomb
- Medical Genetics Unit (UGM), Faculty of Medicine, Saint Joseph University, Beirut, Lebanon
- Roland Tomb
- Department of Dermatology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon
- Edith Chevret
- Bordeaux University, INSERM U1053 Bordeaux Research in Translational Oncology (BaRITOn), Cutaneous Lymphoma Oncogenesis Team, Bordeaux, France
- DOI
- https://doi.org/10.3389/fgene.2020.581115
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
